Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Temporal Epigenetic and Transcriptomic Changes in the Innate and Adaptive Immune Responses in Sepsis

FY 2018-19

Summary
Sepsis is a life-threatening dysregulated immune response to infection associated with organ failure and a high mortality rate. Annually, 5.3 million deaths worldwide and 1 in 18 deaths in Canada involve sepsis. It has been shown that the immune system is overactive at the start of sepsis (a “cytokine storm”), but later on becomes suppressed. The majority of sepsis deaths is attributed to this later immunosuppressive phase which can last weeks to months, since patients’ immune systems are unable to respond to future infections. Thus, the focus on sepsis treatment should move to understanding why immunosuppression persists for such a long time. We hypothesize that epigenetic changes (enduring, non-genetic processes that lead to long-term modified gene expression such as histone modifications) in monocytes and T cells play a key role. Our lab has shown that monocytes, a short-lived innate immune cell type, are unable to respond to pathogens appropriately during septic-like conditions through a process called “cellular reprogramming”. However, since they are short-lived, monocytes alone cannot explain the long duration of immunosuppression. Thus, longer-lived adaptive immune cells such as T cells are likely to be involved, as they may induce reprogramming in new monocytes or become reprogrammed themselves. By analyzing changes in epigenetic regulation and gene expression of monocytes and T cells collected from septic patients at different time points of the disease progression, we can determine the crucial genes and pathways involved in cellular reprogramming and how they change over time. The results from this approach may be used to identify new drug targets, diagnose patients earlier, or predict patient survival, all of which can improve the care of septic patients.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406643
Name
An Andy Y
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Temporal Epigenetic and Transcriptomic Changes in the Innate and Adaptive Immune Responses in Sepsis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cellular Reprogramming; Epigenomics; Immunology; Immunosuppression; Monocytes; Sepsis; Systems Biology; T Cells; Transcriptomics
Abstract
Sepsis is a life-threatening dysregulated immune response to infection associated with organ failure and a high mortality rate. Annually, 5.3 million deaths worldwide and 1 in 18 deaths in Canada involve sepsis. It has been shown that the immune system is overactive at the start of sepsis (a “cytokine storm”), but later on becomes suppressed. The majority of sepsis deaths is attributed to this later immunosuppressive phase which can last weeks to months, since patients’ immune systems are unable to respond to future infections. Thus, the focus on sepsis treatment should move to understanding why immunosuppression persists for such a long time. We hypothesize that epigenetic changes (enduring, non-genetic processes that lead to long-term modified gene expression such as histone modifications) in monocytes and T cells play a key role. Our lab has shown that monocytes, a short-lived innate immune cell type, are unable to respond to pathogens appropriately during septic-like conditions through a process called “cellular reprogramming”. However, since they are short-lived, monocytes alone cannot explain the long duration of immunosuppression. Thus, longer-lived adaptive immune cells such as T cells are likely to be involved, as they may induce reprogramming in new monocytes or become reprogrammed themselves. By analyzing changes in epigenetic regulation and gene expression of monocytes and T cells collected from septic patients at different time points of the disease progression, we can determine the crucial genes and pathways involved in cellular reprogramming and how they change over time. The results from this approach may be used to identify new drug targets, diagnose patients earlier, or predict patient survival, all of which can improve the care of septic patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
An, Andy Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~